19
Jun
2024

Hainan Shuangcheng Pharmaceuticals Co.,Ltd.

Exhibitor at CPHI & PMEC China 2024 stand E3B36, Finished Dosage
About Us

Founded in 2000, Shuangcheng Pharma is a publicly-traded company and engaged in R&D, manufacturing and marketing of both APIs and drug products. Having excellent know-how in peptide chemistry, we are a leader in the field of peptide manufacture, with U.S.FDA and AIFA approved products on market. We supply peptide APIs and drug products, and also provide CDMO services.

The ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand E3B36, Finished Dosage

Products Featured at CPHI & PMEC China 2024

  • Bivalirudin, Bivalirudin for Injection

    Product Bivalirudin, Bivalirudin for Injection

    Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes Bivalirudin and Bivalirudin for Injection (250mg). Contact us for more information.
  • Bortezomib, Bortezomib for Injection (3.5 mg/vial)

    Product Bortezomib, Bortezomib for Injection (3.5 mg/vial)

    Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which include Bortezomib and Bortezomib for Injection (3.5 mg/vial). Contact us for more information.
  • Carbetocin

    Product Carbetocin

    Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes carbetocin . It belongs to generic peptide apis products category. Contact us for more information.